Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Hypesthesia

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Hypesthesia in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Hypesthesia: Absent or reduced sensitivity to cutaneous stimulation.

Research Excerpts

ExcerptRelevanceReference
" Acute or chronic administration of 5-HT1A receptor agonist, 8-OH-DPAT, was performed in olfactory bulbectomy (OB) and sham-operated rats."1.40Chronic administration of 5-HT1A receptor agonist relieves depression and depression-induced hypoalgesia. ( Jiang, ZC; Luo, F; Qi, WJ; Wang, JY, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, ZC1
Qi, WJ1
Wang, JY1
Luo, F1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Hypesthesia

ArticleYear
Chronic administration of 5-HT1A receptor agonist relieves depression and depression-induced hypoalgesia.
    TheScientificWorldJournal, 2014, Volume: 2014

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Depressive Disorder; Hypesthesia; Locomotion; Male;

2014